EffPha at the BIO Asia- Taiwan 2024 International Conference & Exhibition Was a Complete Success

EffPha made a remarkable presentation at the BIO Asia-Taiwan 2024 exhibition, showcasing its exceptional strength as a leading full-service Contract Research Organization (CRO), offering one-stop clinical trial services that cover the entire process from regulatory strategy and submission for drug development to clinical study design, management, and monitoring. Adhering to the philosophy of “beginning with the end in mind”, we focus on meeting the core needs of our clients.

EffPha’s scientific experts bring over 30 years of international pharmaceutical experience in drug development, and we gather a team of skilled scientists with extensive experience in clinical trial designs and regulatory submissions, alongside a professional team with over 25 years of experience in clinical monitoring and management. The EffPha’s experts provided clients with in-depth consultations and discussions at the exhibition, highlighting EffPha's outstanding capabilities in drug development and earning widespread recognition and trust in the industry.
 
One of the key highlights of the exhibition was the visit of Vice President Ms. Bi-khim Hsiao, symbolizing the bright future of Taiwan’s biotech industry. During the exhibition, many industry leaders and experts from both Taiwan and abroad visited the EffPha booth, showing strong interest in our one-stop clinical trial services. This further affirmed our brand influence and excellent reputation. EffPha is well-versed in both Taiwan and U.S. drug regulatory review processes and maintains strong and collaborative relationships with regulatory authorities. This enables us to continually help our clients increase the approval rate of their IND submissions. These achievements reflect the expertise and experience of the EffPha team and our commitment to a client-centered service philosophy.
 
Looking ahead, we will continue to refine our solutions to provide efficient and high-quality services, and work closely with our clients to drive progress and innovation in drug development!